Cite
MLA Citation
T Ikeda et al.. “Long-term outcomes of Japan-specific dosage of rivaroxaban in high-risk patients with non-valvular atrial fibrillation: analysis from the XAPASS.” European heart journal, vol. 41, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100117807716.0x00003d